AEE
56
3
ZTS
19
-36
EW
53
-4
NI
63
-2
CVS
33
-2
ED
45
3
DAL
70
-2
SYK
28
-31
INTU
54
-9
OXY
38
5
MCK
64
-2
QRVO
40
-23
LYB
23
3
PLD
32
-19
XRX
41
-18
PFE
31
-27
URI
42
-26
ADI
70
-6
TSCO
51
-17
IFF
56
3
AEE
56
3
ZTS
19
-36
EW
53
-4
NI
63
-2
CVS
33
-2
ED
45
3
DAL
70
-2
SYK
28
-31
INTU
54
-9
OXY
38
5
MCK
64
-2
QRVO
40
-23
LYB
23
3
PLD
32
-19
XRX
41
-18
PFE
31
-27
URI
42
-26
ADI
70
-6
TSCO
51
-17
IFF
56
3
Financhill
Back

Linde Plc Vs. Ultragenyx Pharmaceutical, Inc. Sector Stock Comparison

Sell
50

LIN
Linde Plc

Last Price:
$420.62
Seasonality Move:
4.11%
Sell
23

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$32.80
Seasonality Move:
-0.96%
Sell
50
Linde Plc (LIN) is a Sell

Is Linde Plc a Buy, Sell or Hold?

  • The current Linde Plc [LIN] share price is $422.34. The Score for LIN is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • LIN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $33.21. The Score for RARE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LIN Stock Price Chart

What is Linde Plc's stock price today?

  • The Linde Plc share price today is $422.34
    The current trend is relatively stagnant and LIN is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

  • The Ultragenyx Pharmaceutical, Inc. share price today is $33.21
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

LIN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.72 Sell
Relative Strength Index (14 RSI): 57.55 Buy
Chaikin Money Flow: -669658 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (400.15 - 421.05) Buy
Bollinger Bands (100): (421.07 - 478.45) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.65 Buy
Relative Strength Index (14 RSI): 43.13 Sell
Chaikin Money Flow: -1062961 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.65 - 35.95) Sell
Bollinger Bands (100): (29.01 - 34.13) Buy

LIN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 406.85 Buy
20-day SMA: 407.57 Buy
50-day SMA: 425.08 Sell
200-day SMA: 454.69 Sell
8-day EMA: 412.81 Buy
20-day EMA: 411.55 Buy
50-day EMA: 424.27 Sell
200-day EMA: 447.16 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.62 Sell
20-day SMA: 34.63 Sell
50-day SMA: 33.66 Sell
200-day SMA: 33.65 Sell
8-day EMA: 7.38 Buy
20-day EMA: 3.16 Buy
50-day EMA: 1.3 Buy
200-day EMA: 0.33 Buy

Linde Plc Earnings Growth & LIN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.96 per share, and an increase next year of $1.41 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

Linde Plc Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):